A recognized leader in the field of Vascular Surgery, Dr. Muck performs the most complex procedures and trains other health care professionals in vascular methods. He has been the program director of TriHealth Vascular Surgery since 2007. His surgical expertise includes minimally invasive treatments of all types of problems of the circulatory system, including carotid stents, transcarotid artery revascularization (TCAR) and complex aneurisms, performing them on patients throughout southern Ohio, Indiana and Kentucky. His proficiency in treatment of vascular issues also extends to: • Aortic aneurysms • Carotid artery disease • Chronic venous insufficiency • Deep vein thrombosis • Peripheral vascular disease • Varicose veins

Dr. Muck's leadership roles and board appointments most recently have included the American Venous Forum (spanning 26 countries) and the Midwestern Vascular Surgical Society, where he serves on the Executive Council. He has been called upon to share his knowledge through presentations and meetings nationally and internationally, including in Africa, Asia, Australia, Europe and South America.

At TriHealth, Dr. Muck is the director of the TriHealth Vascular Fellowship Program. He advances vascular care by training the next generation of vascular surgeons. He participates in and leads clinical trials, offering patients the latest vascular treatments. He presently is serving as the primary investigator (PI) in a 30-site national trial studying the treatment of pulmonary embolism.

A Northern Kentucky native and graduate of the University of Kentucky and the University of Notre Dame, Dr. Muck has strong regional connections. His wife is from Augusta, KY, where they also have a home. He is committed to finding circulatory solutions for patients throughout southern Ohio, Indiana and Kentucky to improve their quality of life.

In the News

Health Talk Live: Breakthrough Treatment for Blood Clots | TriHealth

TriHealth On Call: Minimally-Invasive Treatment of Varicose Veins | TriHealth

Gut Check: Leading the Way with Minimally Invasive Abdominal Aortic Aneurysm Surgery | TriHealth

Vascular Team Helps Edward Buyinski Reach His Goals | TriHealth

Good Samaritan Hospital First in Cincinnati to Offer New, Robotic Treatment Option for Vascular Disease | TriHealth

TriHealth Physicians First Local Team to Use New Device | TriHealth

Good Samaritan One of 20 Centers in the World Participating in Clinical Trial | TriHealth

Treating an Aortic Aneurysm with a Stent Graft | TriHealth

Clinical Studies

• Crest 2– sponsor: NINDS – started 12/2018 – currently active
  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis. Learn More.
   
• STRIKE PE – sponsor: Penumbra, Inc. – started 5/2022 – currently active
  Prospective, Multicenter study of the Indigo Aspiration System seeking to evaluate the long-term safety and outcomes of treating PE. Learn More.
   
• BOLT – sponsor: Penumbra, Inc. – started 1/2022 – currently active
  Prospective, Multicenter study of patients with DVT to evaluate the safety and efficacy of the indigo aspiration system. Learn More.
   
• GORE CONFORMABLE AAA – sponsor: W.L Gore and Associates – started 5/2018 – currently active
  Assessment of Gore Excluder Conformable AAA Endoprosthesis in the treatment of AAA. Learn More.  
   
• Hancock Jaffe (SAVVE) Study – sponsor: Hancock Jaffe – started 7/2021 – currently active
  The Hancock Jaffe Surgical Antireflux Venous Valve Endoprothesis study. Learn More.
   
• Ranger – sponsor: Boston Scientific – started 5/2017; closed
  Randomized trial comparing the Boston Scientific RANGER Paclitaxel Coated Balloon vs Standard Balloon Angioplasty for the treatment of superficial arteries (SFA) and proximal popliteal arteries (PPA)
   
• INSIGHT IDE – sponsor: Avinger – started 5/2018; closed
  Evaluation of the Pantheris OCT- Imaging Atherectomy System For Treatment of In-Stent Restenosis (ISR) Lesions In Lower Extremity Arteries